Do patients with advanced liver cancer need to stop cabozantinib?

Whether patients with advanced liver cancer need to stop taking cabozantinib involves many aspects, including the patient's condition, the side effects of the drug, and the doctor's advice.

Cabotinib is a multi-target tyrosine kinase inhibitor that has been approved by the FDA to treat certain types of cancer, such as relapsed and refractory advanced medullary thyroid cancer and advanced renal cancer that have failed Sutent treatment. For patients with advanced liver cancer, cabozantinib may have a certain effect, but the specific effect varies from person to person. Therefore, whether cabozantinib needs to be discontinued, the first thing to consider is whether the patient's condition is suitable for continued use of this drug.

Although cabozantinib may provide some benefits, it may also cause side effects. Common side effects include diarrhea, nausea and vomiting, constipation, stomatitis, hand-foot syndrome, gastrointestinal bleeding, and cardiotoxicity. These side effects may adversely affect the patient's quality of life. Therefore, the efficacy and side effects of cabozantinib need to be weighed when deciding whether to discontinue cabozantinib.

Most importantly, whether patients with advanced liver cancer should discontinue cabozantinib should be decided based on the professional advice of their doctors. The doctor will comprehensively consider the patient's condition, physical condition, drug response, quality of life and other factors to give the most appropriate advice. Patients should maintain close communication with their doctors and provide timely feedback on drug reactions and physical conditions so that doctors can make accurate judgments and adjust treatment plans.

For the treatment of advanced liver cancer, in addition to targeted drugs such as cabozantinib, other treatments can also be considered, such as analgesic, hemostasis, ascites pumping and other symptomatic treatments, as well as immunotherapy, interventional therapy, etc. These treatments can be selected and combined according to the patient's specific conditions under the guidance of a doctor.